RESEARCH TRIANGLE PARK, N.C., May 15 /PRNewswire/ -- Dennis Gillings,
CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated a
new Quintiles facility in Overland Park, Kan., with Secretary David Kerr of
the Kansas Department of Commerce and other dignitaries attending.
The four-story, 236,000-square-foot building is the new home of
Quintiles' regional Clinical Development Services (CDS) and Clinical
Pharmacology units previously located in Kansas City, Mo., as well as the
Phase I Clinical Research unit that had been in nearby Lenexa, Kan. The new
Phase I unit has a 150-bed capacity, triple the space in the Lenexa unit,
and the building provides room for up to 200 more employees.
The new facility gives the Overland Park office room it needs to expand
its activities in support of regional and global clinical research,
Gillings said. "Ultimately, however, this building is about even more than
the creation of jobs in Overland Park and the growth of Quintiles," he
said. "It is about improving healthcare -- for people in Kansas, across the
United States and around the world."
Dignitaries attending the event included Thomas Thornton, President and
CEO of the Kansas Bioscience Authority, and Carl Gerlach, Mayor of Overland
Park.
Stan McDermott, Vice President and General Manager, Clinical
Development Services, Quintiles, Overland Park, said: "This expansion is
good for Quintiles and benefits the state of Kansas and the Kansas City
metropolitan area. It will bring many highly skilled jobs to the region and
contribute to the growth of bioscience in the area."
Quintiles employs about 750 full-time workers in the Kansas City area
in CDS, Clinical Pharmacology and Phase I.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With about 17,000
employees and offices in more than 50 countries, it is focused on providing
customers with solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at http://www.quintiles.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
CONTACT:
Media Relations, Dick Jones,
media.info@quintiles.com, +1-919-998-2091; or Investor Relations,
Greg Connors, invest@quintiles.com, +1-919-998-2000, both of
Quintiles Transnational Corp.
|
